Tcw Group Inc Vertex Pharmaceuticals Inc Transaction History

Tcw Group Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$187.49 - $221.1 $2.25 Million - $2.65 Million	-11,981 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$207.02 - $241.31 $1,242 - $1,447	6 Added 0.05%	11,981 $2.58 Million
Q4 2020 Feb 02, 2021	BUY	$207.01 - $276.09 $2.48 Million - $3.31 Million	11,975 New	11,975 $2.83 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.